18F-Sodium Fluoride (NaF) PET/CT in obese patients on LYSO PET/CT system: Patient dosimetry, optimization of injected activity and acquisition time.

Conclusion: 18F-NaF PET/CT can be beneficial in obese patients due to its better pharmacokinetics. Optimal osseous staging can be achieved with relatively low doses and radiation burden. Lesion delineation was excellent regardless of the various acquisition times assessed. However, it is recommended to do 3min per bed position acquisition in patients with BMI >40. PMID: 33380519 [PubMed - as supplied by publisher]
Source: Journal of Nuclear Medicine Technology - Category: Nuclear Medicine Tags: J Nucl Med Technol Source Type: research